Literature DB >> 12858416

Detection of human papillomavirus in urine and cervical swabs from patients with invasive cervical cancer.

Grazyna A Stanczuk1, Patti Kay, Bruce Allan, Mike Chirara, Sam A Tswana, Staffan Bergstrom, Elopy N Sibanda, Anna-Lise Williamson.   

Abstract

Despite the high prevalence of both human papillomavirus (HPV) infections and cervical cancer among Zimbabwean women, the ability to test for HPV infection of the uterine cervix is limited by a lack of an easy sample collection method that does not require gynecological examination. The presence of HPVs in urine and cervical swab samples collected from 43 women who presented with invasive cervical cancer was investigated. HPV detection was done by means of degenerate primers in a nested polymerase chain reaction (PCR). Typing of HPVs was done using restriction fragment length polymorphism (RFLP) analysis. HPV was identified and typed in 98% (42/43) of cervical swabs and 72% (31/43) of paired urine samples. HPV type 16 was the most common (25/42, 59%), followed by types: 33 (13/42, 31%), 18 (6/42, 14%), and 31 (1/42, 2%). Type-specific concordance between cervical and urine samples was high (22/28, 79%). Therefore, the HPV types identified in urine samples in most cases represent the same HPV type infecting the cervical epithelium. The results suggest that urine may be a practical sample for testing of HPV urogenital infection. Further research is required before the detection of HPV in urine can be applied in the routine cervical screening programs. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12858416     DOI: 10.1002/jmv.10456

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  13 in total

Review 1.  Detection of human papillomavirus DNA in urine. A review of the literature.

Authors:  A Vorsters; I Micalessi; J Bilcke; M Ieven; J Bogers; P Van Damme
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-08-05       Impact factor: 3.267

2.  Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinic.

Authors:  Vikrant V Sahasrabuddhe; Patti E Gravitt; S Terence Dunn; David Brown; Richard A Allen; Yolanda J Eby; Katie Smith; Rosemary E Zuna; Roy R Zhang; Michael A Gold; Mark Schiffman; Joan L Walker; Philip E Castle; Nicolas Wentzensen
Journal:  J Clin Microbiol       Date:  2013-11-06       Impact factor: 5.948

3.  Classical molecular tests using urine samples as a potential screening tool for human papillomavirus detection in human immunodeficiency virus-infected women.

Authors:  Marina Munoz; Milena Camargo; Sara C Soto-De Leon; Ricardo Sanchez; Andrea C Pineda-Peña; Antonio Perez-Prados; Manuel E Patarroyo; Manuel A Patarroyo
Journal:  J Clin Microbiol       Date:  2013-08-28       Impact factor: 5.948

4.  Clinical efficacy of human papillomavirus DNA detection in urine from patients with various cervical lesions.

Authors:  Eun-Seop Song; Hun Jae Lee; Tae Sook Hwang
Journal:  J Korean Med Sci       Date:  2007-02       Impact factor: 2.153

Review 5.  Human papillomavirus genotypes in cervical cancer and vaccination challenges in Zimbabwe.

Authors:  Nyasha Chin'ombe; Natasha L Sebata; Vurayai Ruhanya; Hilda T Matarira
Journal:  Infect Agent Cancer       Date:  2014-05-13       Impact factor: 2.965

Review 6.  Accuracy of urinary human papillomavirus testing for presence of cervical HPV: systematic review and meta-analysis.

Authors:  Neha Pathak; Julie Dodds; Javier Zamora; Khalid Khan
Journal:  BMJ       Date:  2014-09-16

Review 7.  Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis.

Authors:  Rebecca Kemunto Ogembo; Philimon Nyakauru Gona; Alaina J Seymour; Henry Soo-Min Park; Paul A Bain; Louise Maranda; Javier Gordon Ogembo
Journal:  PLoS One       Date:  2015-04-14       Impact factor: 3.240

8.  Estimation of HPV prevalence in young women in Scotland; monitoring of future vaccine impact.

Authors:  Kimberley Kavanagh; Katy Sinka; Kate Cuschieri; John Love; Alison Potts; Kevin G J Pollock; Heather Cubie; Martin Donaghy; Chris Robertson
Journal:  BMC Infect Dis       Date:  2013-11-05       Impact factor: 3.090

9.  A Versatile Nanowire Platform for Highly Efficient Isolation and Direct PCR-free Colorimetric Detection of Human Papillomavirus DNA from Unprocessed Urine.

Authors:  HyungJae Lee; Mihye Choi; Sang-Hyun Hwang; Youngnam Cho
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

10.  Monitoring human papillomavirus prevalence in urine samples: a review.

Authors:  Espen Enerly; Cecilia Olofsson; Mari Nygård
Journal:  Clin Epidemiol       Date:  2013-03-12       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.